mercredi 24 avril 2019

Onco Actu du 24 avril 2019


1. BIOLOGIE



Pancreatic cancers ‘talk’ to neighbouring cells in mice, pointing to potential new drug targets [Cancer Research UK]











1.4 BIOLOGIE - TECHNOS



Watch: Cells are the building blocks of life. Scientists are making a map to understand them [STAT]










2.4 ETIOLOGIE - PORTABLES, ONDES E-M



IARC Urged To Revisit RF Risk [Microwave News]











3.1 PRÉVENTION - TABAC



Walgreens Raises Tobacco-Buying Age to 21, Strengthening a Consensus [NY Times]











4.10 DÉP., DIAG. & PRONO. - POUMON



What If We Could Stop Lung Cancer Before It Starts? [Boston University]










Can differences in genomic immune system signatures detect lung cancer before it takes hold? [EndPoints]











4.2 DÉP., DIAG. & PRONO. - GÉNOME



Multiple myeloma: DNA rearrangements may predict resistance, poor outcomes [Emory University]











4.3 DÉP., DIAG. & PRONO. - INDUSTRIELS



Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy [Roche]











5.1 TRAITEMENTS - PRÉ-CLINIQUE



The future hope of “flash” radiation cancer therapy [Stanford]











Imaging system helps surgeons remove tiny ovarian tumors [MIT]











Study: Drugs reprogram genes in breast tumors to prevent endocrine resistance [University of Illinois]











5.10 TRAITEMENTS - ESSAIS



Cancers controlled better when hit with multiple genetic drugs, UCSD study finds [San Diego Union Tribune]











5.12.2 IMMUNOTHÉRAPIES - CAR-T, THÉRAPIES CELLULAIRES



USC-led advance in groundbreaking cancer treatment eliminates severe side effects [USC]











As safety looms larger in CAR-T research, study highlights how small tweaks can make it easier to use [EndPoints]











5.12.8 IMMUNOTHÉRAPIES - ECONOMIE



Medicare proposes higher payments for innovative cancer treatment [Washington Post]











Medicare offers to partially raise payment for cancer CAR-Ts [Reuters]











5.2 PHARMA



The Changing Landscape of Research and Development [IQVIA]










Biotechs getting bigger in late-stage R&D, leaving Big Pharmas behind: report [Fierce Biotech]











5.3 TRAITEMENTS - FDA, EMA, NICE...



U.S. biologics and biosimilars need distinguishable names [STAT]











5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)



How real world evidence was used to support approval of Ibrance for male breast cancer [The Cancer Letter]










5.4 TRAITEMENTS - ECONOMIE



Top 10 Best-Selling Cancer Drugs of 2018 [GEN]











5.6 ESMO



Innovation at the heart of breast cancer care: First ESMO Breast Cancer Congress [ESMO]











6. LUTTE CONTRE LES CANCERS



NCI advisors approve eight concepts, including three Cancer Moonshot concepts [The Cancer Letter]










6.11 PATIENTS



The breast cancer surgeon who got breast cancer [BBC News]











6.6 PUBLICATIONS



Should I publish in an open access journal? [BMJ]










6.7 DMP, BIG DATA & APPLIS



Hancock: NHS must adopt new technology or it will not survive [The Telegraph]











6.9 CONTROVERSES



After firings, MD Anderson officials try to calm fears of racial profiling [Science]